This impressive track record easily grabs the attention of the investment community. However, some open-minded investors ...

With market uncertainty rising, investors are favoring defensive ETFs. Healthcare, gold miners, and nuclear energy funds are among the top picks in 2025.

Israel Englander of Millennium Management bought 12.6 million shares of the iShares Bitcoin Trust, increasing his stake by ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Swiss biotech Bioversys AG shares started trading at 36.5 Swiss francs ($40.29) on the SIX Swiss Exchange on Friday, slightly up from the final price for its initial public offering (IPO) of 36 Swiss ...

Caprock Group LLC purchased a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) in the 4th quarter, HoldingsChannel.com reports. The institutional investor purchased 3,344 ...

Detailed price information for Virtus Lifesci Biotech Clinical Trials ETF (BBC-A) from The Globe and Mail including charting and trades.

The tit-for-tat tariffs ignite fears of a trade war, prompting investors to dump riskier assets and take a flight to safety.

Shares MSCI Kuwait ETF (KWT) offers high yield potential despite stability concerns, supported by Kuwait's improving economic ...

January was full of events and surprises for Wall Street. Here are the five top-performing ETFs that were the leaders in January.